Related Experiment Video
Updated: Apr 1, 2026

09:16
Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants
Published on: February 21, 2015
20.7K
Microarray CGH analysis of hematological patients with del(20q).
Chunxiao Wu1, Jinlan Pan2, Huiying Qiu1
1Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, 188 shizi street, Suzhou, 215006, People's Republic of China.
International Journal of Hematology
|October 7, 2015
Summary
Deletion of chromosome 20 long arm (del(20q)) is linked to blood cancers. Microarray CGH precisely mapped these deletions, identifying key regions and potential genes for further study in hematologic malignancies.
Area of Science:
- Genetics and Genomics
- Hematology
- Cancer Research
Background:
- Deletion of the long arm of chromosome 20 (del(20q)) is a recurrent chromosomal abnormality frequently observed in hematologic malignancies.
- Accurate characterization of del(20q) is crucial for understanding its role in disease pathogenesis and for potential therapeutic targeting.
Purpose of the Study:
- To precisely define the genomic regions involved in del(20q) in patients with hematologic diseases using microarray comparative genomic hybridization (aCGH).
- To identify commonly deleted regions (CDRs) and commonly retained regions (CRRs) within 20q.
- To explore potential candidate genes within these defined regions and investigate the role of copy number variations in hematologic disorders.
Main Methods:
- Analysis of 21 patients with hematologic diseases carrying del(20q) confirmed by conventional cytogenetics and fluorescence in situ hybridization.
- Application of aCGH to precisely map deletion breakpoints and identify copy number variations.
- Utilized the UCSC Genome Browser to identify candidate genes within the defined CDRs and CRRs.
Main Results:
- Seventeen out of 21 patients showed del(20q), with both continuous and discrete deletion patterns observed.
- Defined three commonly deleted regions (CDRs) and two commonly retained regions (CRRs) on chromosome 20q.
- Observed duplications in retained regions (20q11.21 and 20p13-p11.21) associated with specific hematologic conditions (M6, MDS).
Conclusions:
- aCGH is a valuable tool for high-resolution mapping of del(20q) breakpoints in hematologic malignancies.
- The identified CDRs and CRRs provide a refined genomic map for investigating the genes involved in del(20q)-associated hematologic diseases.
- Further research is warranted to identify specific pathogenic genes within these critical genomic regions.

